Epinephrine induces a late thromboxane-dependent platelet shape change and enhances synergistically the shape change induced by other platelet agonists

Platelets

Volumn 7, Issue 1-2, 1996, Pages 35-42

  Blockmans, D ^a   Deckmyn, H ^a   De Vos, R ^a   Vermylen, J ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE; ADRENALIN; ARACHIDONIC ACID; COLLAGEN; THROMBOCYTE ACTIVATING FACTOR; THROMBOXANE;

ARTICLE; CONTROLLED STUDY; ELECTRON MICROSCOPY; HUMAN; HUMAN CELL; NORMAL HUMAN; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION; THROMBOCYTE RICH PLASMA; THROMBOCYTE SHAPE;

EID: 0029810519     PISSN: 09537104     EISSN: None     Source Type: Journal    
DOI: 10.3109/09537109609079507     Document Type: Article

References (27)

1. O'Brien JR. Platelet stickiness. Ann Rev Med, 1966; 17: 275-90.
2. Born GVR. Observations on the change in shape of blood platelets brought about by adenosine diphosphate. J Physiol 1970; 209: 487-511.
3. Patscheke H, Wörner P. Platelet activation detected by turbidometric shape-change analysis. Differential influence of cytochalasin B and prostaglandin E1. Thromb Res 1978; 12: 485-96.
4. Patscheke H. Correlation of activation and aggregation of platelets. Discrimination between anti-activating and anti-aggregating agents. Haemostasis 1979; 8: 65-81.
5. White JG, Platelet microtubules and microfilaments: effects of cytochalasin B on structure and function. In: Caen J, ed. Platelet Aggregation. Paris: Masson, 1971: 15-52.
6. Milton JG, Frojmovic MM. Adrenaline and adenosine diphosphate induced platelet aggregation require shape change. J Lab Clin Med 1984; 104: 805-15.
7. Estensen RD, White JG. Ultrastructural features of the platelet response to phorbol myristate acetate. Am J Path 1974; 4: 441-52.
8. Regan JW, Nakatah, De Marinis RM, Caron MG, Lefkowitz RJ. Purification and characterization of the human platelet alfa2-adrenergic receptor. J Biol Chem 1986; 261: 3894-97.
9. 2+ concentration. Ear J Biochem 1986; 161: 399-408.
10. + removal on aggregation, secretion and c-AMP accumulation. J Biol Chem 1983; 258: 3907-12.
11. Motulsky HJ, Shattil SJ, Ferry N, Rozansky D, Insel PA. Desensitization of epinephrine-initiated platelet aggregation does not alter binding to the α2-adrenergic receptor or receptor coupling to adenylate cyclase. Mol Pharmacol 1986; 29; 1-6.
12. Jackson SP, Yuan Y, Schoenwaelder SM, Mitchell CA. Role of platelet integrin glycoprotein IIb-IIIa in intracellular signalling. Thromb Res 1993; 71: 159-68.
13. Nieuwland R, Wijburg OLC, Van Willigen G, Akkerman JWN. Alfa-2A adrenergic receptors activate protein kinase C in human platelets via a pertussis toxin-sensitive G-protein. FEBS Lett 1994; 339: 79-83.
14. Resink TJ, Bühler FR. The influence of epinephrine on washed. human platelets: shape change and protein phosphorylation. J Recept Res 1984; 4: 537-56.
15. Nakano T, Terawaki A, Arita H. Signal transduction in collagen-stimulated rat platelets is composed of three stages. J Biochem 1987; 101; 1169-80.
16. Keraly CL, Kinlough-Rathbone RL, Packham MA, Suzuki H, Mustard JF. Conditions affecting the responses of human platelets to epinephrine. Thromb Haemos 1988; 60: 209-16.
17. Piche LA, Mahadevappa VG. Aggregation and/or oxygenated products of arachidonic acid are not required for collagen-induced deacylation of phosphatidylcholine in human platelets. Biochem J 1989; 263: 143-8.
18. Daniel JL, Molish IR, Rigmaiden M, Stewart G. Evidence for a role of myosin phosphorylation in the initiation of the platelet shape change response. J Biol Chem 1984; 259: 9826-31.
19. Ware JA, Johnson PC, Smith M, Salzman EW. Effect of common agonists on cytoplasmic ionized calcium concentration in platelets. J Clin Invest 1986; 77: 878-86.
20. Siess W, Lapetina EG. Platelet aggregation induced by alfa 2-adrenoceptor and protein kinase C activation. A novel synergism. Biochem J 1989; 263: 377-85.
21. Steen VM, Holmsen H, Aarbakke G. The platelet-stimulating effect of adrenaline through α2-adrenergic receptors requires simultaneous activation by a true stimulatory platelet agonist. Evidence that adrenaline per se does not induce human platelet activation in vitro. Thromb Haemost 1993; 70: 506-13.
22. Goto S, Ikeda Y, Murata M, Handa M, Takahashi E, Yoshioka A, Fujimura Y, Fukuyama M, Handa S, Ogawa S. Epinephrine augments von Willebrand factor-dependent shear induced platelet aggregation. Circulation 1992; 86: 1859-63.
23. Rinder CS, Student LA, Bonan JL, Rinder HM, Smith BR. Aspirin does not inhibit diphosphate-induced platelet a granule release. Blood 1993; 82: 505-12.
24. Sano K, Takai Y, Yamanishi J, Nishizuka Y. A role of calcium-activated phospholipid-dependent protein kinase in human platelet activation. J Biol Chem 1983; 258: 2010-13.
25. Haslam RJ, Lynham JA. Relationship between phosphorylation of blood platelet proteins and secretion of platelet granule constituents. I. Effects of different aggregating agents. Biochem Biophys Res Commun 1977; 77: 714-22.
26. Hathaway DR, Adelstein RS. Human platelet myosin light chain kinase requires the calcium-binding protein calmodulin for activity. Proc Natl Acad Sci USA 1979; 76: 1653-57.
27. Figures WR, Scearce M, Wachtfogel Y, Chen J, Colman RF, Colman RW. Platelet ADP receptor and α2-adrenoceptor interaction. J Biol Chem 1986; 261: 5981-86.